282 related articles for article (PubMed ID: 25469528)
1. Effect of probiotics (Saccharomyces boulardii) on microbial translocation and inflammation in HIV-treated patients: a double-blind, randomized, placebo-controlled trial.
Villar-García J; Hernández JJ; Güerri-Fernández R; González A; Lerma E; Guelar A; Saenz D; Sorlí L; Montero M; Horcajada JP; Knobel Freud H
J Acquir Immune Defic Syndr; 2015 Mar; 68(3):256-63. PubMed ID: 25469528
[TBL] [Abstract][Full Text] [Related]
2. Impact of probiotic Saccharomyces boulardii on the gut microbiome composition in HIV-treated patients: A double-blind, randomised, placebo-controlled trial.
Villar-García J; Güerri-Fernández R; Moya A; González A; Hernández JJ; Lerma E; Guelar A; Sorli L; Horcajada JP; Artacho A; D Auria G; Knobel H
PLoS One; 2017; 12(4):e0173802. PubMed ID: 28388647
[TBL] [Abstract][Full Text] [Related]
3. Reduced Levels of D-dimer and Changes in Gut Microbiota Composition After Probiotic Intervention in HIV-Infected Individuals on Stable ART.
Stiksrud B; Nowak P; Nwosu FC; Kvale D; Thalme A; Sonnerborg A; Ueland PM; Holm K; Birkeland SE; Dahm AE; Sandset PM; Rudi K; Hov JR; Dyrhol-Riise AM; Trøseid M
J Acquir Immune Defic Syndr; 2015 Dec; 70(4):329-37. PubMed ID: 26258571
[TBL] [Abstract][Full Text] [Related]
4. A 12 week longitudinal study of microbial translocation and systemic inflammation in undernourished HIV-infected Zambians initiating antiretroviral therapy.
Canipe A; Chidumayo T; Blevins M; Bestawros M; Bala J; Kelly P; Filteau S; Shepherd BE; Heimburger DC; Koethe JR
BMC Infect Dis; 2014 Sep; 14():521. PubMed ID: 25266928
[TBL] [Abstract][Full Text] [Related]
5. Correlation between different methods to measure microbial translocation and its association with immune activation in long-term suppressed HIV-1-infected individuals.
Abad-Fernández M; Vallejo A; Hernández-Novoa B; Díaz L; Gutiérrez C; Madrid N; Muñoz MA; Moreno S
J Acquir Immune Defic Syndr; 2013 Oct; 64(2):149-53. PubMed ID: 24047967
[TBL] [Abstract][Full Text] [Related]
6. Plasma Biomarkers of Risk of Tuberculosis Recurrence in HIV Co-Infected Patients From South Africa.
Pillay K; Lewis L; Rambaran S; Yende-Zuma N; Archary D; Gengiah S; Govender D; Hassan-Moosa R; Samsunder N; Abdool Karim SS; McKinnon LR; Padayatchi N; Naidoo K; Sivro A
Front Immunol; 2021; 12():631094. PubMed ID: 33841412
[TBL] [Abstract][Full Text] [Related]
7. Long-term Use of Proton Pump Inhibitors Is Associated With Increased Microbial Product Translocation, Innate Immune Activation, and Reduced Immunologic Recovery in Patients With Chronic Human Immunodeficiency Virus-1 Infection.
Serpa JA; Rueda AM; Somasunderam A; Utay NS; Lewis D; Couturier JP; Breaux KG; Rodriguez-Barradas M
Clin Infect Dis; 2017 Oct; 65(10):1638-1643. PubMed ID: 29020215
[TBL] [Abstract][Full Text] [Related]
8. Synbiotic therapy decreases microbial translocation and inflammation and improves immunological status in HIV-infected patients: a double-blind randomized controlled pilot trial.
González-Hernández LA; Jave-Suarez LF; Fafutis-Morris M; Montes-Salcedo KE; Valle-Gutierrez LG; Campos-Loza AE; Enciso-Gómez LF; Andrade-Villanueva JF
Nutr J; 2012 Oct; 11():90. PubMed ID: 23101545
[TBL] [Abstract][Full Text] [Related]
9. Saccharomyces boulardii for the prevention of antibiotic-associated diarrhea in adult hospitalized patients: a single-center, randomized, double-blind, placebo-controlled trial.
Pozzoni P; Riva A; Bellatorre AG; Amigoni M; Redaelli E; Ronchetti A; Stefani M; Tironi R; Molteni EE; Conte D; Casazza G; Colli A
Am J Gastroenterol; 2012 Jun; 107(6):922-31. PubMed ID: 22472744
[TBL] [Abstract][Full Text] [Related]
10. Involvement of the LPS-LPB-CD14-MD2-TLR4 inflammation pathway in HIV-1/HAART-associated lipodystrophy syndrome (HALS).
Viladés C; Escoté X; López-Dupla M; Martinez E; Domingo P; Asensi V; Leal M; Peraire J; Inza MI; Arnedo M; Gutiérrez M; Valle-Garay E; Ferrando-Martinez S; Olona M; Alba V; Sirvent JJ; Gatell JM; Vidal F;
J Antimicrob Chemother; 2014 Jun; 69(6):1653-9. PubMed ID: 24535275
[TBL] [Abstract][Full Text] [Related]
11. Effects of Co-Trimoxazole on Microbial Translocation in HIV-1-Infected Patients Initiating Antiretroviral Therapy.
Vesterbacka J; Barqasho B; Häggblom A; Nowak P
AIDS Res Hum Retroviruses; 2015 Aug; 31(8):830-6. PubMed ID: 26059763
[TBL] [Abstract][Full Text] [Related]
12. Cytokine and clinical response to Saccharomyces boulardii therapy in diarrhea-dominant irritable bowel syndrome: a randomized trial.
Abbas Z; Yakoob J; Jafri W; Ahmad Z; Azam Z; Usman MW; Shamim S; Islam M
Eur J Gastroenterol Hepatol; 2014 Jun; 26(6):630-9. PubMed ID: 24722560
[TBL] [Abstract][Full Text] [Related]
13. Probiotics Reduce Inflammation in Antiretroviral Treated, HIV-Infected Individuals: Results of the "Probio-HIV" Clinical Trial.
d'Ettorre G; Ceccarelli G; Giustini N; Serafino S; Calantone N; De Girolamo G; Bianchi L; Bellelli V; Ascoli-Bartoli T; Marcellini S; Turriziani O; Brenchley JM; Vullo V
PLoS One; 2015; 10(9):e0137200. PubMed ID: 26376436
[TBL] [Abstract][Full Text] [Related]
14. Plasma Biomarkers of Human Immunodeficiency Virus-Related Systemic Inflammation and Immune Activation in Sub-Saharan Africa Before and During Suppressive Antiretroviral Therapy.
Kroeze S; Wit FW; Rossouw TM; Steel HC; Kityo CM; Siwale M; Akanmu S; Mandaliya K; de Jager M; Ondoa P; Reiss P; Rinke de Wit TF; Kootstra N; Hamers RL
J Infect Dis; 2019 Aug; 220(6):1029-1033. PubMed ID: 31086991
[TBL] [Abstract][Full Text] [Related]
15. Can Probiotics Reduce Inflammation and Enhance Gut Immune Health in People Living with HIV: Study Designs for the Probiotic Visbiome for Inflammation and Translocation (PROOV IT) Pilot Trials.
Kim CJ; Walmsley SL; Raboud JM; Kovacs C; Coburn B; Rousseau R; Reinhard R; Rosenes R; Kaul R
HIV Clin Trials; 2016 Jul; 17(4):147-57. PubMed ID: 27267710
[TBL] [Abstract][Full Text] [Related]
16. Markers of microbial translocation during pregnancy: differences among HIV+ women of African and European provenance.
Baroncelli S; Galluzzo CM; Molinari A; Pirillo MF; Cavalli A; Negri E; Floridia M; Degli Antoni A
J Infect Dev Ctries; 2020 Feb; 14(2):184-190. PubMed ID: 32146453
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulation of antiretroviral drug-suppressed chronic HIV-1 infection in an oral probiotic double-blind placebo-controlled trial.
Yang OO; Kelesidis T; Cordova R; Khanlou H
AIDS Res Hum Retroviruses; 2014 Oct; 30(10):988-95. PubMed ID: 25127924
[TBL] [Abstract][Full Text] [Related]
18. Immune Activation and Microbial Translocation Markers in HIV-Exposed Uninfected Malawian Infants in the First Year of Life.
Baroncelli S; Galluzzo CM; Liotta G; Andreotti M; Mancinelli S; Mphwere R; Bokola E; Amici R; Marazzi MC; Palombi L; Palmisano L; Giuliano M
J Trop Pediatr; 2019 Dec; 65(6):617-625. PubMed ID: 31006009
[TBL] [Abstract][Full Text] [Related]
19. Probiotic effects on immunity and microbiome in HIV-1 discordant patients.
Blázquez-Bondia C; Parera M; Català-Moll F; Casadellà M; Elizalde-Torrent A; Aguiló M; Espadaler-Mazo J; Santos JR; Paredes R; Noguera-Julian M
Front Immunol; 2022; 13():1066036. PubMed ID: 36569851
[TBL] [Abstract][Full Text] [Related]
20. Saccharomyces boulardii does not prevent relapse of Crohn's disease.
Bourreille A; Cadiot G; Le Dreau G; Laharie D; Beaugerie L; Dupas JL; Marteau P; Rampal P; Moyse D; Saleh A; Le Guern ME; Galmiche JP;
Clin Gastroenterol Hepatol; 2013 Aug; 11(8):982-7. PubMed ID: 23466709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
